Inclusion Criteria:~* Male or females~* Age at least 55 years or older~* Mild-to-moderate Alzheimer's Disease,
with Mini Mental State Examination (MMSE) between 18 and 26, inclusive, Modified Hachinski Ischemic Scale
(MHIS) score =/<4, Global CDR score of 1 or 2, and who have a reliable informant/caregiver to accompany patient
to all clinic visits~* If using symptomatic Alzheimer's Disease treatments, patients must be on the medication
for 3 months and on a STABLE DOSE for at least 2 months~
